샘플 요청 목록

 카트 문의
시장보고서
상품코드
1665904

조직공학 시장 : 성장, 전망, 경쟁 분석(2025-2033년)

Tissue Engineering Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 171 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 조직공학 시장은 역동적이고 빠르게 진화하는 시장으로, 헬스케어에 큰 영향을 미치고 치료에 혁명을 일으킬 수 있는 잠재력이 특징입니다. 시장 규모는 2023년부터 2033년까지 크게 증가할 것으로 예상되며, 이 산업은 다양한 요인의 수렴으로 상당한 성장 잠재력을 보여주고 있습니다. 조직공학의 핵심은 생체재료, 세포, 공학기술의 조합을 통해 기능적인 조직과 장기를 개발하는 것입니다. 이 혁신적인 접근법은 손상된 조직을 복구하거나 대체할 수 있는 생체적합성 구조를 만들어 장기 부족, 만성 질환, 조직 손상과 같은 심각한 의료 문제를 해결할 수 있을 것으로 기대됩니다. 세계 조직공학 시장 규모는 2024년 181억 달러에 달했습니다. 향후 14.21%의 연평균 복합 성장률(CAGR)로 확대되어 2033년에는 610억 8,000만 달러에 달할 것으로 예상됩니다. 이러한 성장 전망은 조직공학이 환자 치료를 혁신하고 헬스케어의 전망을 재구성할 수 있다는 인식이 확산되고 있음을 뒷받침합니다.

세계 고령화는 세계 조직공학 시장의 성장을 가속하는 중요한 요인입니다. 세계보건기구(WHO)에 따르면, 60세 이상의 세계 인구는 2050년까지 21억 명에 달할 것으로 예상됩니다. 나이가 들어감에 따라 만성질환, 장기부전, 조직 손상에 대한 감수성이 증가합니다. 이러한 인구 통계학적 변화는 노화와 관련된 건강 문제를 해결할 수 있는 혁신적인 재생 치료법의 시급한 필요성을 강조하고 있습니다. 조직공학은 손상된 조직을 젊어지게 하고 대체할 수 있는 맞춤형 솔루션을 제공하여 환자의 예후와 삶의 질을 향상시킬 수 있으며, WHO는 2050년까지 전 세계 60세 이상 노인의 수가 5세 미만 어린이보다 많을 것으로 예측했습니다. 미국 국립노화연구소(NIA)는 노화가 심혈관질환, 당뇨병, 신경퇴행성 질환 등 만성질환의 주요 위험요인이라고 보고하고 있습니다.

세계의 조직공학(Tissue Engineering) 시장에 대해 조사했으며, 시장 개요, 유형별/용도별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서문

제2장 주요 요약

제3장 조직공학 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택한 전략
  • 주요 업계 전략

제4장 조직공학 시장 : 매크로 분석과 시장 역학

  • 서론
  • 세계의 조직공학 시장 가치, 2023년-2033년
  • 시장 역학
  • 성장 촉진요인과 억제요인의 영향 분석
  • See-Saw 분석
  • Porter's Five Forces 모델
  • PESTEL 분석

제5장 조직공학 시장 : 유형별, 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화
    • 합성 스캐폴드 재료
    • 생물 유래 스캐폴드 재료
    • 기타

제6장 조직공학 시장 : 용도별, 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화
    • 정형외과 및 근골격
    • 신경학
    • 심혈관
    • 피부 및 외피
    • 치과
    • 기타

제7장 북미의 조직공학 시장 : 2023년-2033년

제8장 영국 및 EU의 조직공학 시장 : 2023년-2033년

제9장 아시아태평양의 조직공학 시장 : 2023년-2033년

제10장 라틴아메리카의 조직공학 시장 : 2023년-2033년

제11장 중동 및 아프리카의 조직공학 시장 : 2023년-2033년

제12장 기업 개요

  • Integra LifeSciences
  • Zimmer Biomet
  • Organogenesis Holdings Inc.
  • AbbVie(Allergan)
  • B. Braun Melsungen SE
  • Becton Dickinson and Company
  • Stryker Corporation
  • Medtronic plc
  • Smith &Nephew plc
  • Axogen
  • Baxter International Inc.
  • TissueTech Inc.
  • Vericel Corporation
  • Tissue Regenix Group
  • Athersys Inc
  • 3M
LSH 25.03.12

The global tissue engineering market presents a dynamic and rapidly evolving landscape, characterized by its profound impact on healthcare and the potential to revolutionize medical treatments. With a market value projected to increase significantly from 2023 to 2033, the industry showcases remarkable growth potential driven by a convergence of factors. Tissue engineering, at its core, involves the development of functional tissues and organs through a combination of biomaterials, cells, and engineering techniques. This innovative approach holds the promise of addressing critical medical challenges, including organ shortages, chronic diseases, and tissue damage, through the creation of biocompatible structures that restore or replace damaged tissues. The global market's value, which stood at $18.10 billion in 2024, is anticipated to grow at a CAGR of 14.21%, reaching $61.08 billion by 2033. This forecasted growth underscores the increasing recognition of tissue engineering's potential to transform patient care and reshape the healthcare landscape.

Aging Population and Chronic Diseases

The aging population worldwide is a significant driver propelling the growth of the global tissue engineering market. According to the World Health Organization (WHO), the global population aged 60 years and older is expected to reach 2.1 billion by 2050. With age comes an increased susceptibility to chronic diseases, organ failures, and tissue damage. This demographic shift underscores the urgent need for innovative regenerative therapies that can address age-related health issues. Tissue engineering offers tailored solutions to rejuvenate and replace damaged tissues, enhancing patient outcomes and quality of life. WHO predicts that by 2050, the number of people aged 60 years and older will outnumber children under 5 years globally. The National Institute on Aging (NIA) reports that aging is a leading risk factor for chronic diseases such as cardiovascular diseases, diabetes, and neurodegenerative disorders.

Challenges in Regulatory Pathways

One of the significant restraints facing the tissue engineering market is the intricate regulatory landscape surrounding regenerative therapies. The innovative nature of tissue engineering, which involves the convergence of biology and technology, presents unique challenges for regulatory authorities. Ensuring the safety, efficacy, and quality of tissue-engineered products requires careful evaluation and validation processes that can be time-consuming and resource-intensive. Regulators must strike a balance between facilitating innovation and safeguarding patient health. Variability in regulatory approaches across different countries and regions further adds complexity. Companies operating in the tissue engineering sector need to invest substantial resources to meet regulatory requirements, including conducting rigorous preclinical and clinical studies to demonstrate safety and efficacy. The International Society for Stem Cell Research (ISSCR) emphasizes that the regulatory landscape for stem cell-based therapies is evolving and varies widely by jurisdiction, posing challenges for developers and researchers. The U.S. Food and Drug Administration (FDA) requires robust evidence to support the safety and efficacy of tissue-engineered products, contributing to the length of the regulatory approval process.

Long-Term Safety and Efficacy

A critical challenge in tissue engineering is ensuring the long-term safety and efficacy of tissue-engineered products. While early clinical trials may show promising results, the durability of these therapies over extended periods remains a concern. The dynamic and complex interactions between engineered tissues and the patient's body raise questions about potential adverse effects, immune responses, and the potential for unexpected long-term consequences. Developing comprehensive and long-term follow-up strategies to monitor patients' health outcomes and track the performance of tissue-engineered products is essential for building confidence in the field and optimizing patient care.

Cross-Disciplinary Collaborations

One of the promising opportunities in tissue engineering lies in fostering cross-disciplinary collaborations. The convergence of biology, engineering, materials science, and other fields offers a fertile ground for innovation. Collaborations between scientists, engineers, clinicians, and industry experts can accelerate the development of novel tissue-engineered solutions, leveraging diverse perspectives and expertise to address complex challenges. Such collaborations can lead to groundbreaking advancements by integrating cutting-edge technologies and methodologies from various disciplines.

Market Segmentation by Type

As of 2024, the largest segment in the global tissue engineering market is the biologically derived scaffold material by type. The dominance of the biologically derived scaffold material segment can be attributed to several factors. biologically derived scaffold materials are derived from natural sources such as proteins, peptides, and extracellular matrices, making them inherently biocompatible and capable of mimicking the body's natural environment. This characteristic is particularly crucial in tissue engineering, as it facilitates better cell attachment, proliferation, and tissue regeneration. As a result, biologically derived scaffold materials have gained significant attention and preference in various applications within the field.

Market Segmentation by Application

As of 2024, the largest segment in the global tissue engineering market by application is orthopedics and musculoskeletal. This prominence can be attributed to several key factors. The orthopedics and musculoskeletal segment's significant market share is driven by several factors that highlight its importance in the tissue engineering landscape: Musculoskeletal disorders, including bone fractures, joint injuries, and degenerative conditions like osteoarthritis, are common worldwide. These conditions often result in compromised mobility and quality of life. Tissue engineering offers innovative solutions to restore function and repair damaged tissues in the musculoskeletal system, driving substantial demand.

Market Segmentation by Region

As of 2024, the largest geography in the global tissue engineering market is North America. This prominence can be attributed to several significant factors that contribute to North America's leadership in the tissue engineering landscape. North America boasts a well-developed healthcare infrastructure, including advanced medical facilities, research institutions, and a strong network of healthcare professionals. This foundation provides a conducive environment for the adoption of innovative medical technologies like tissue engineering.

Key players identified for tissue engineering market include Integra LifeSciences, Zimmer Biomet, Organogenesis Holdings Inc., AbbVie (Allergan), B. Braun Melsungen SE, Becton, Dickinson and Company, Stryker Corporation, Medtronic plc, Smith & Nephew plc, Axogen, Baxter International Inc., TissueTech, Inc., Vericel Corporation,Tissue Regenix Group, Athersys, Inc, 3M.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Tissue Engineering market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Tissue Engineering market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Type
    • Synthetic Scaffold Material
  • Synthetic Polymer
  • Others
    • Biologically Derived Scaffold Material
  • Collagen
  • Others
    • Others
  • Application
    • Orthopedics and Musculoskeletal
    • Neurology
    • Cardiovascular
    • Skin and Integumentary
    • Dental
    • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Tissue Engineering market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Tissue Engineering market?
  • Which is the largest regional market for Tissue Engineering market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Tissue Engineering market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Tissue Engineering market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Tissue Engineering Market
  • 2.2. Global Tissue Engineering Market, By Type, 2024 (US$ Million)
  • 2.3. Global Tissue Engineering Market, By Application, 2024 (US$ Million)
  • 2.4. Global Tissue Engineering Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. Tissue Engineering Market: Competitive Analysis

  • 3.1. Market Positioning of Key Tissue Engineering Market Vendors
  • 3.2. Strategies Adopted by Tissue Engineering Market Vendors
  • 3.3. Key Industry Strategies

4. Tissue Engineering Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Tissue Engineering Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Tissue Engineering Market: By Type, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Synthetic Scaffold Material
      • 5.3.1.1. Synthetic Polymer
      • 5.3.1.2. Others
    • 5.3.2. Biologically Derived Scaffold Material
      • 5.3.2.1. Collagen
      • 5.3.2.2. Others
    • 5.3.3. Others

6. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Orthopedics and Musculoskeletal
    • 6.3.2. Neurology
    • 6.3.3. Cardiovascular
    • 6.3.4. Skin and Integumentary
    • 6.3.5. Dental
    • 6.3.6. Others

7. North America Tissue Engineering Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
  • 7.3. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
  • 7.4.Tissue Engineering Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 7.4.1.1.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 7.4.1.2.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 7.4.1.3.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

8. UK and European Union Tissue Engineering Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
  • 8.3. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
  • 8.4.Tissue Engineering Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.1.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.2.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.3.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.4.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.5.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 8.4.1.6.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

9. Asia Pacific Tissue Engineering Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
  • 9.3. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
  • 9.4.Tissue Engineering Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.1.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.2.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.3.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.4.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.5.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 9.4.1.6.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

10. Latin America Tissue Engineering Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
  • 10.3. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
  • 10.4.Tissue Engineering Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 10.4.1.1.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 10.4.1.2.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 10.4.1.3.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

11. Middle East and Africa Tissue Engineering Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
  • 11.3. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
  • 11.4.Tissue Engineering Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 11.4.1.1.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 11.4.1.2.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Tissue Engineering Market: By Type, 2023-2033, USD (Million)
        • 11.4.1.3.2. Tissue Engineering Market: By Application, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. Integra LifeSciences
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Zimmer Biomet
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Organogenesis Holdings Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. AbbVie (Allergan)
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. B. Braun Melsungen SE
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Becton, Dickinson and Company
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Stryker Corporation
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Medtronic plc
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Smith & Nephew plc
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Axogen
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Baxter International Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. TissueTech, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. Vericel Corporation
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives
  • 12.14. Tissue Regenix Group
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Initiatives
  • 12.15. Athersys, Inc
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Portfolio
    • 12.15.4. Strategic Initiatives
  • 12.16. 3M
    • 12.16.1. Company Overview
    • 12.16.2. Financial Performance
    • 12.16.3. Product Portfolio
    • 12.16.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제